AbbVie, Scripps Research to collaborate on COVID-19 treatments

2021 08 23 18 25 2180 Covid Treatment Doctor 400

AbbVie and Scripps Research plan to collaborate on developing antiviral treatments for COVID-19.

The initial research program was conducted at Calibr, Scripps Research's drug discovery and development division, and received funding from the Bill & Melinda Gates Foundation.

Page 1 of 2
Next Page